Physicians Can Be Trained to Interpret Axumin PET Images of Recurrent Prostate Cancer, Study Finds

Physicians Can Be Trained to Interpret Axumin PET Images of Recurrent Prostate Cancer, Study Finds
A study supported by Blue Earth Diagnostics showed that physicians can be trained to successfully interpret Axumin PET scan images of patients with suspected recurrence of prostate cancer. Axumin is the first F-18 PET imaging agent approved for use in men with suspected recurrent prostate cancer, based on increased blood levels of PSA following treatment. The study, “
Subscribe or to access all post and page content.